Therapy Areas: Diabetes
18 January 2019 - - US-based biopharmaceutical company Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO) has completed patient dosing in the company's TIME-2b study, a Phase 2b clinical trial designed ...
18 January 2019 - - A new paper in Science Translational Medicine showcases the discovery and development of TTP399, an investigational, oral, small molecule, liver-selective glucokinase act...
18 January 2019 - Pharmaceuticals company Amedex Inc said on Thursday that it plans to conduct two Phase 2 cDFU clinical trial for its topically applied Nu-3 antimicrobial used to eliminate infection ...
17 January 2019 - - US-based clinical stage biopharma company Dance Biopharm Holdings Inc. has appointed Dr. Melissa Rhodes to the position of chief development officer and Michael Kaseta to the role ...
17 January 2019 - - US-based biotechnology company PharmaCyte Biotech, Inc. (OTCQB: PMCB) partner Austrianova has successfully encapsulated the live cells used in PharmaCyte's therapy for it...
10 January 2019 - - US-based drug developer AgeX Therapeutics, Inc. (NYSE American: AGE) has published data relating to its cell therapy product candidate AgeX-BAT1 for Type II diabetes and obesity in...